Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Autoimmune
Cancer
Cardiovascular
COVID-19
Health Topics
Infectious
Infectious
FDA grants 510(k) clearance to DiaSorin for COVID-19 and flu A/B assay
The test detects and differentiates influenza A, influenza B, and SARS-CoV-2 viruses to help ensure physicians can recommend the most appropriate treatment for each patient.
March 20, 2023
Cue Health receives FDA emergency use authorization for molecular mpox test
The test demonstrated high accuracy in clinical trials, achieving 100% concordance with the Center for Disease Control and Prevention’s (CDC's) mpox test on the samples tested, Cue Health said.
March 20, 2023
Researchers in Spain demonstrate HCV RNA detection, genotyping using dried blood spot samples
The research shows the potential of using dried blood spot samples for determining cure rates and differentiating between reinfection and relapse after antiviral treatment in people who inject drugs.
March 20, 2023
Becton Dickinson nabs FDA clearance for infectious vaginitis molecular test
The BD vaginal panel running on the high-throughput BD Cor molecular diagnostic system tests for multiple common types of vaginitis using only a swab and one test.
March 16, 2023
Noze nabs $1M grant from Bill & Melinda Gates Foundation to develop breath testing platform
The aim is to develop a platform that enables rapid screening and diagnostic testing for infectious diseases such as malaria and tuberculosis that impact millions of people, particularly in developing countries, Noze said.
March 14, 2023
National hepatitis C elimination program represents an historic opportunity, according to White House
The Biden-Harris administration proposes a five-year program to expand screening, testing, treatment, and prevention of hepatitis C, focusing on high-risk populations.
March 14, 2023
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Cue Health Q4 revenues decline 24% as firm expands, diversifies POC test menu
Calibre Scientific acquires AlphaScience to expand product portfolio, customer reach
AlphaScience will be integrated with Biozol Diagnostica, a subsidiary of Calibre Scientific, expanding its sales capabilities and product range for customers in the DACH region that comprises Germany, Austria, and Switzerland.
March 13, 2023
Electronic health record interventions reduce unnecessary urine culture orders, study finds
According to the study, electronic health record interventions can significantly reduce unnecessary urine culture orders, resulting in cost savings and improved patient care.
March 2, 2023
Laser light method identifies bacteria in fluids
An innovative way of shining a laser on a minute drop of blood, mucus, or wastewater enables the reflected light to identify the bacteria within.
March 3, 2023
Birmingham AIDS Outreach, Binx Health launch accessible HIV/STI testing program in Alabama
The program will serve the Birmingham, AL, metro area by providing access to self-collection kits for HIV and sexually transmitted infections (STIs) through a network of trusted partners that work with higher-risk populations.
March 1, 2023
Roche, CDC expand partnership on HIV and TB support for healthcare systems in critical regions
The public-private partnership, named Lab Networks for Health, aims to improve HIV and TB detection, prevention, and treatment in countries that have been hit hardest by the two diseases.
February 28, 2023
Chembio Diagnostics obtains FDA CLIA waiver for HIV-syphilis testing system
More than 200,000 CLIA-waived point-of-care testing sites in the U.S. can now use the system to detect HIV and syphilis, Richard Eberly, Chembio’s president and CEO, said in a statement.
February 24, 2023
Page 1 of 140
Next Page
